Injection-site reaction to etanercept: Role of skin test in the diagnosis of such reaction and successful desensitization

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 9, 2011, Pages 1256-1257

  Bavbek, S ^a   Aydin, A ^b   Ataman, S ^b   Cahill, K ^b   Castells, M ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE

Author keywords

desensitization; etanercept; injection site reaction; subcutaneous desensitization

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ANTIHISTAMINIC AGENT; CETIRIZINE; DIPHENHYDRAMINE; ETANERCEPT; IMMUNOGLOBULIN E; INDOMETACIN; INFLIXIMAB; MONTELUKAST; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; CASE REPORT; CLINICAL PROTOCOL; DESENSITIZATION; DISEASE ACTIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE SWELLING; MALE; PRICK TEST; PRIORITY JOURNAL; PRURITUS; SHORT SURVEY; SKIN TEST; TREATMENT DURATION; URTICARIA;

ADULT; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN G; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN TESTS; SPONDYLITIS, ANKYLOSING;

EID: 79961128929     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02601.x     Document Type: Short Survey

References (6)

1. Zochling J, van der HD, Burgos-Vargas R, Collantes E, Davis JC, Dijkmans B, et al., ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006; 65: 442-452.
2. Braun J, Davis J, Dougados M, Sieper J, Van der Linden S, van der Heijde D,. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 2006; 65: 316-320. (Pubitemid 43268219)
3. Davis JC Jr, van der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, et al., Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 2003; 48: 3230-3236. (Pubitemid 37409337)
4. Zeltser R, Valle L, Tanck C, Holyst MM, Ritchlin C, Gaspari AA,. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha-receptor: Fc fusion protein. Arch Dermatol 2001; 137 (7): 893-899. (Pubitemid 32641648)
5. Winfield H, Lain E, Horn T, Hoskyn J,. Eosinophilic cellulitis like reaction to subcutaneous etanercept injection. Arch Dermatol 2006; 142: 218-220. (Pubitemid 43276535)
6. Benucci M, Manfredi M, Demoly P, Campi P,. Injection site reactions to TNF-α blocking agents with positive skin tests. Allergy 2008; 63: 138-139. (Pubitemid 350198239)